How ACH, SWIFT, domestic wires and real-time rails differ on speed, cost and reversibility, and what it means for ASX ...
Two watershed moments for the AI revolution are coming and they are the Anthropic IPO and the OpenAI IPO. Both events are a ...
CoreWeave (NSDQ:CRVW) carries more than US$52bn of debt and lease obligations as investors question whether its AI growth can ...
Rocket Lab (NASDAQ:RKLB) stock jumped 4% despite its Neutron rocket delay to 2027. Discover what's driving investor interest ...
Madrigal Pharmaceuticals (NDQ:MDGL) is attempting something unusual in modern biotech in scaling a first‑in‑class therapy for ...
Nvidia (NVDA) stock jumped 3% as Anthropic's IPO filing, Morgan Stanley research and SpaceX's $40B AI financing boosted ...
Cochlear (ASX:COH) reaffirmed FY27 profit guidance of $330m to $350m at today's AGM after a soft FY26 and a reset of the ...
Genmab (NDQ:GMAB) enters FY26 as one of the most profitable royalty engines in global oncology. The company’s antibody ...
United Therapeutics (NDQ:UNTR) is the only listed company attempting to industrialise the supply of transplantable organs.
Tuas (ASX:TUA) plunged after Singapore's IMDA escalated its Simba probe, raising the risk of spectrum restrictions, fines and licence action.
AML3D (ASX:AL3) wins a ~A$2.2m ARCEMY X order from Northrop Grumman, its first US Navy prime customer win in a growing ...
Pureprofile (ASX:PPL) posted record Q1 FY27 revenue of A$18.3m as Platform revenue doubled and EBITDA margin expanded to 13%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results